<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: effectiveness research</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Comorbidities should be factor in prostate biopsy choice, study finds</title>
   	 <description>UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) and the physician-reported Charlson Comorbidity Index – can successfully target prostate patients who would not benefit from biopsy to discover possible cancer.</description>
     <link>http://medicalxpress.com/news/2013-05-comorbidities-factor-prostate-biopsy-choice.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 May 2013 09:18:45 EST</pubDate>
	 <guid isPermaLink="false">news287828319</guid>
	 
</item>
<item>
     <title>Regional anesthesia technique significantly improves outcomes of hip and knee replacement</title>
   	 <description>A highly underutilized anesthesia technique called neuraxial anesthesia, also known as spinal or epidural anesthesia, improves outcomes in patients undergoing hip or knee replacement, according to a new study by researchers at Hospital for Special Surgery. The study, which appears in the May issue of the journal Anesthesiology, found that neuraxial anesthesia, a type of regional anesthesia, reduced morbidity, mortality, length of hospital stay and costs when compared with general anesthesia.</description>
     <link>http://medicalxpress.com/news/2013-04-regional-anesthesia-technique-significantly-outcomes.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 01 May 2013 00:00:07 EST</pubDate>
	 <guid isPermaLink="false">news286563849</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/regionalanes.jpg" width="90" height="90" />
</item>
<item>
     <title>Can computer-based decision support control health care costs?</title>
   	 <description>William M. Tierney, M.D. focuses on the potential of electronic medical systems and computer-based decision support to control healthcare costs in &quot;Controlling costs with computer-based decision support: a hammer, a scalpel or an illusion?&quot; published online in JAMA Internal Medicine on April 15.</description>
     <link>http://medicalxpress.com/news/2013-04-computer-based-decision-health.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 16 Apr 2013 15:47:31 EST</pubDate>
	 <guid isPermaLink="false">news285346043</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/cancomputerb.jpg" width="90" height="90" />
</item>
<item>
     <title>Sharing individual health information could improve care and reduce costs for all, researcher says</title>
   	 <description>Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.</description>
     <link>http://medicalxpress.com/news/2013-04-individual-health.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 15 Apr 2013 16:05:09 EST</pubDate>
	 <guid isPermaLink="false">news285260703</guid>
	 
</item>
<item>
     <title>Is medical therapy a better and safer choice than angioplasty</title>
   	 <description>The decision to perform an invasive procedure to open clogged arteries in the heart instead of first trying medication and lifestyle changes may not reduce a patient's risk of death or of a major cardiac event. Unnecessary procedures to treat chronic, stable heart disease contribute to rising health care costs. A targeted approach to avoiding this kind of overutilization by instead relying on evidence-based decision-making is presented in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Population Health Management website at http://www.liebertpub.com/bari.</description>
     <link>http://medicalxpress.com/news/2013-04-medical-therapy-safer-choice-angioplasty.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 09 Apr 2013 12:35:29 EST</pubDate>
	 <guid isPermaLink="false">news284729717</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/ismedicalthe.jpg" width="90" height="90" />
</item>
<item>
     <title>Costly breast cancer screenings don't add up to better outcomes</title>
   	 <description>Even though Medicare spends over $1 billion per year on breast cancer screenings such as a mammography, there is no evidence that higher spending benefits older women, researchers at Yale School of Medicine found in a study published Online First by JAMA Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-01-costly-breast-cancer-screenings-dont.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 07 Jan 2013 16:00:13 EST</pubDate>
	 <guid isPermaLink="false">news276772358</guid>
	 
</item>
<item>
     <title>Despite hype, costly prostate cancer treatment offers little relief from side effects</title>
   	 <description>Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a standard radiation treatment called intensity modulated radiotherapy (IMRT), Yale School of Medicine researchers report in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-12-hype-costly-prostate-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 13 Dec 2012 16:30:08 EST</pubDate>
	 <guid isPermaLink="false">news274638592</guid>
	 
</item>
<item>
     <title>Heart failure in older breast cancer patients linked to medication</title>
   	 <description>Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin), Yale School of Medicine researchers report in the current issue of the Journal of the American College of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-11-heart-failure-older-breast-cancer.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 14 Nov 2012 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news272129356</guid>
	 
</item>
<item>
     <title>Patient-reported outcomes essential to comparative effectiveness research</title>
   	 <description>Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.</description>
     <link>http://medicalxpress.com/news/2012-10-patient-reported-outcomes-essential-effectiveness.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Oct 2012 13:41:44 EST</pubDate>
	 <guid isPermaLink="false">news269613691</guid>
	 
</item>
<item>
     <title>Strategies proposed to improve impact of comparative effectiveness studies</title>
   	 <description>Comparative effectiveness research conducted over the past decade has had a limited impact on the way medical care is delivered, but many opportunities exist to help doctors and others in the medical system translate such research into better patient care, according to a new RAND Corporation study.</description>
     <link>http://medicalxpress.com/news/2012-10-strategies-impact-effectiveness.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 09 Oct 2012 16:33:53 EST</pubDate>
	 <guid isPermaLink="false">news269019224</guid>
	 
</item>
<item>
     <title>Rising cost of inpatient care linked to medical devices and supplies</title>
   	 <description>Inpatient hospital treatment accounts for the largest proportion of health care spending in the U.S., with the use of diagnostic imaging services such as MRIs, frequently implicated as the probable cause.  A new analysis finds that the biggest expense may not be imaging technology but from supplies including medical devices, such as stents and artificial joints. &quot;One of the take-away messages for hospitals is that they should examine their own data in closer detail to explore the costs that are rapidly rising and have a better understanding for the underlying reasons,&quot; said lead author Jared Lane Maeda, Ph.D., of Truven Health Analytics in Washington, D.C.</description>
     <link>http://medicalxpress.com/news/2012-08-inpatient-linked-medical-devices.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 29 Aug 2012 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news265447154</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/risingcostof.jpg" width="90" height="90" />
</item>
<item>
     <title>ICD-9 codes underestimate statin-linked rhabdomyolysis</title>
   	 <description>(HealthDay) -- Use of diagnostic codes, such as International Classification of Diseases -- Ninth Revision (ICD-9) codes, may result in misclassification of rare, adverse drug reactions (ADRs), including the risk of rhabdomyolysis from high-dose simvastatin, according to a research letter published in the April 18 issue of the Journal of the American Medical Association, a theme issue on comparative effectiveness research.</description>
     <link>http://medicalxpress.com/news/2012-04-icd-codes-underestimate-statin-linked-rhabdomyolysis.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 18 Apr 2012 01:20:01 EST</pubDate>
	 <guid isPermaLink="false">news253928794</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ltigticd9lti.jpg" width="90" height="90" />
</item>
<item>
     <title>Bioethicists urge less regulatory burden for low-risk comparative effectiveness research</title>
   	 <description>In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them &amp;#150; as is now proposed &amp;#150; solely for low-risk social and behavior research involving surveys, interviews and focus groups.</description>
     <link>http://medicalxpress.com/news/2012-04-bioethicists-urge-regulatory-burden-low-risk.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 17 Apr 2012 16:00:08 EST</pubDate>
	 <guid isPermaLink="false">news253884280</guid>
	 
</item>
<item>
     <title>Need for greater patient and clinician involvement in comparative clinical effectiveness research</title>
   	 <description>More involvement by patients, clinicians and others in the health care community in developing comparative clinical effectiveness research studies will make such studies far more useful in clinical decision-making, according to the Patient-Centered Outcomes Research Institute, in an article published in the April 18 issue of JAMA, a theme issue on comparative effectiveness research.</description>
     <link>http://medicalxpress.com/news/2012-04-greater-patient-clinician-involvement-clinical.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 17 Apr 2012 11:10:01 EST</pubDate>
	 <guid isPermaLink="false">news253878701</guid>
	 
</item>
<item>
     <title>Study examines drug regimen for the treatment of non-small cell lung cancer among older patients</title>
   	 <description>Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA, a theme issue on comparative effectiveness research.</description>
     <link>http://medicalxpress.com/news/2012-04-drug-regimen-treatment-non-small-cell.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 17 Apr 2012 10:51:03 EST</pubDate>
	 <guid isPermaLink="false">news253878657</guid>
	 
</item>
<item>
     <title>Study examines adverse effects among different radiation therapies for prostate cancer</title>
   	 <description>In an analysis of three different types of radiation therapy used to treat localized prostate cancer, compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more erectile dysfunction, while proton therapy was associated with more gastrointestinal adverse effects than IMRT, according to a study in the April 18 issue of JAMA, a theme issue on comparative effectiveness research.</description>
     <link>http://medicalxpress.com/news/2012-04-adverse-effects-therapies-prostate-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 17 Apr 2012 10:48:19 EST</pubDate>
	 <guid isPermaLink="false">news253878493</guid>
	 
</item>
<item>
     <title>New fee coming for medical effectiveness research</title>
   	 <description>Starting in 2012, the government will charge a new fee to your health insurance plan for research to find out which drugs, medical procedures, tests and treatments work best. But what will Americans do with the answers?</description>
     <link>http://medicalxpress.com/news/2011-12-fee-medical-effectiveness.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 28 Dec 2011 03:42:12 EST</pubDate>
	 <guid isPermaLink="false">news244266124</guid>
	 
</item>


</channel>
</rss>
